Brad Graveline is a partner in the Intellectual Property and Litigation Practice Groups in Sheppard Mullin’s Chicago office. He has more than 20 years of experience litigating patent infringement cases, trademark disputes and other commercial matters. His patent infringement experience involves a variety of technologies, including pharmaceuticals, medical devices, nutrition supplements, biologics and wireless communications. He has particular expertise in Hatch-Waxman litigation and has represented pharmaceutical companies in over twenty-five ANDA cases. Mr. Graveline frequently represents highly visible clients in high-stakes cases, and he has served as lead trial and appeal counsel in a variety of federal and state courts. In addition to patent litigation experience, he has worked on a wide array of other commercial cases in the areas of product liability, securities, civil and criminal antitrust, and class action defense.
262
FTC v. Actavis: What Does It Mean for Reverse-Payment Settlements?* On June 17, 2013, the United States Supreme Court announced a rule that blurs the lines between antitrust and patent law in the context of Hatch-Waxman litigation. In FTC v. Actavis, 570 U.S. 756 (2013), the Federal Trade (...)
19 avenue Jean Aicard
75011 Paris, France
106 West 32nd Street, Suite 149
New York, NY, 10001, USA
563 Chiswick High Road
W4 3AY London, UK